Cargando…

Detection of SARS-CoV-2 Specific Antibodies in Saliva Samples

Molecular assays on nasopharyngeal swabs act as a confirmatory test in coronavirus disease (COVID-19) diagnosis. However, the technical requirements of nasopharyngeal sampling and molecular assays limit the testing capabilities. Recent studies suggest the use of saliva for the COVID-19 diagnostic te...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Siyang, Zhang, Peiyan, Liao, Mingfeng, Zhang, Juanjuan, Luo, Suisui, Zhai, Jinglei, Zhang, Yaxi, Lin, Jingyan, Yuan, Jing, Zhang, Zheng, Wang, Fuxiang, Wei, Lanlan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309249/ https://www.ncbi.nlm.nih.gov/pubmed/35898491 http://dx.doi.org/10.3389/fimmu.2022.880154

Ejemplares similares

Single-cell RNA sequencing reveals TCR(+) macrophages in HPV-related head and neck squamous cell carcinoma
por: Jiang, Yourong, et al.
Publicado: (2022)

Saliva-Based ELISAs for Effective SARS-CoV-2 Antibody Monitoring in Vaccinated Individuals
por: Casian, Joseph G., et al.
Publicado: (2021)

Non-Invasive Antibody Assessment in Saliva to Determine SARS-CoV-2 Exposure in Young Children
por: Heinzel, Constanze, et al.
Publicado: (2021)

Evaluating SARS-CoV-2 antibody reactivity to natural exposure and inactivated vaccination with peptide microarrays
por: Zheng, Peiyan, et al.
Publicado: (2023)

Detection of Antibody Responses Against SARS-CoV-2 in Plasma and Saliva From Vaccinated and Infected Individuals
por: Klingler, Jéromine, et al.
Publicado: (2021)

Saliva is suitable for SARS-CoV-2 antibodies detection after vaccination: A rapid systematic review
por: Guerra, Eliete Neves Silva, et al.
Publicado: (2022)

Natural SARS-CoV-2 Infection Affects Neutralizing Activity in Saliva of Vaccinees
por: Garziano, Micaela, et al.
Publicado: (2022)

SARS-CoV-2 Antibodies Are Persisting in Saliva for More Than 15 Months After Infection and Become Strongly Boosted After Vaccination
por: Pinilla, Yudi T., et al.
Publicado: (2021)

Novel Monoclonal Antibodies and Recombined Antibodies Against Variant SARS-CoV-2
por: Xie, Jiajia, et al.
Publicado: (2021)

The analysis of cathepsin L that mediates cellular SARS‐CoV‐2 infection leading to COVID‐19 in head and neck squamous cell carcinoma
por: Gao, Feng, et al.
Publicado: (2023)

Multiplex Antibody Analysis of IgM, IgA and IgG to SARS-CoV-2 in Saliva and Serum From Infected Children and Their Close Contacts
por: Dobaño, Carlota, et al.
Publicado: (2022)

Blood and saliva SARS-CoV-2 antibody levels in self-collected dried spot samples
por: Lahdentausta, Laura, et al.
Publicado: (2022)

ELISA detection of SARS-CoV-2 antibodies in saliva
por: MacMullan, Melanie A., et al.
Publicado: (2020)

Saliva SARS-CoV-2 Antibody Prevalence in Children
por: Keuning, Maya W., et al.
Publicado: (2021)

A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants
por: Shan, Sisi, et al.
Publicado: (2021)

Long-Term Kinetics of SARS-CoV-2 Antibodies and Impact of Inactivated Vaccine on SARS-CoV-2 Antibodies Based on a COVID-19 Patients Cohort
por: Zhang, Shihan, et al.
Publicado: (2022)

Serial semiquantitative detection of SARS-CoV-2 in saliva samples
por: Mao, Ming-Hui, et al.
Publicado: (2021)

Distinct Microbiomes of Gut and Saliva in Patients With Systemic Lupus Erythematous and Clinical Associations
por: Liu, Fengping, et al.
Publicado: (2021)

SARS-CoV-2 Omicron Variants Reduce Antibody Neutralization and Acquire Usage of Mouse ACE2
por: Wang, Ruoke, et al.
Publicado: (2022)

Double lock of a potent human therapeutic monoclonal antibody against SARS-CoV-2
por: Zhu, Ling, et al.
Publicado: (2020)

SARS-CoV-2 identification and IgA antibodies in saliva: One sample two tests approach for diagnosis
por: Aita, Ada, et al.
Publicado: (2020)

Saliva as a gold-standard sample for SARS-CoV-2 detection
por: Tan, Steph H, et al.
Publicado: (2021)

Increased SARS-CoV-2 Testing Capacity with Pooled Saliva Samples
por: Watkins, Anne E., et al.
Publicado: (2021)

Saliva Sampling for Prospective SARS-CoV-2 Screening of Healthcare Professionals
por: Raimann, Adalbert, et al.
Publicado: (2022)

Pilot genome-wide association study of antibody response to inactivated SARS-CoV-2 vaccines
por: Li, Ping, et al.
Publicado: (2022)

Intranasal Lentiviral Vector-Mediated Antibody Delivery Confers Reduction of SARS-CoV-2 Infection in Elderly and Immunocompromised Mice
por: Du, Yue, et al.
Publicado: (2022)

A Rapid and Efficient Screening System for Neutralizing Antibodies and Its Application for SARS-CoV-2
por: Han, Xiaojian, et al.
Publicado: (2021)

The impact of CoronaVac on the neutralization breadth and magnitude of the antibody response to SARS-CoV-2 viruses
por: Zhang, Lu, et al.
Publicado: (2022)

58: SARS-COV-2 ANTIBODY CHARACTERISTICS OF SALIVA FROM VACCINATED INDIVIDUALS
por: Ota, K., et al.
Publicado: (2022)

Recent advances in RNA sample preparation techniques for the detection of SARS-CoV-2 in saliva and gargle
por: Liu, Yanming, et al.
Publicado: (2023)

The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections
por: Zhang, Yun-yu, et al.
Publicado: (2020)

Two Different Antibody-Dependent Enhancement (ADE) Risks for SARS-CoV-2 Antibodies
por: Ricke, Darrell O.
Publicado: (2021)

Preclinical characterization of amubarvimab and romlusevimab, a pair of non-competing neutralizing monoclonal antibody cocktail, against SARS-CoV-2
por: Ji, Yun, et al.
Publicado: (2022)

SARS-CoV-2 tetrameric RBD protein blocks viral infection and induces potent neutralizing antibody response
por: Liu, Zheng, et al.
Publicado: (2022)

Does sampling saliva increase detection of SARS-CoV-2 by RT-PCR? Comparing saliva with oro-nasopharyngeal swabs
por: Dogan, Ozlem Akgun, et al.
Publicado: (2021)

Patient-derived monoclonal antibodies to SARS-CoV-2 nucleocapsid protein N-terminal and C-terminal domains cross-react with their counterparts of SARS-CoV, but not other human betacoronaviruses
por: Wen, Yingfen, et al.
Publicado: (2023)

Evaluation of Sample Pooling for SARS-CoV-2 Detection in Nasopharyngeal Swab and Saliva Samples with the Idylla SARS-CoV-2 Test
por: Hofman, Paul, et al.
Publicado: (2021)

Hexamerization of Anti-SARS CoV IgG1 Antibodies Improves Neutralization Capacity
por: Pande, Kalyan, et al.
Publicado: (2022)

Impact of Hydroxychloroquine on Antibody Responses to the SARS-CoV-2 Coronavirus
por: de Miranda Santos, Isabel Kinney Ferreira, et al.
Publicado: (2020)

Saliva sampling for chasing SARS-CoV-2: A Game-changing strategy
por: Borghi, Elisa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6ijiper8hm68t650boh750n6gt